SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-20-000800
Filing Date
2020-02-06
Accepted
2020-02-06 17:26:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8471886_sc13g-a.htm SC 13G/A 76631
  Complete submission text file 0000919574-20-000800.txt   78169
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Subject) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90572 | Film No.: 20583720
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Filed by) CIK: 0001534261 (see all company filings)

IRS No.: 800752351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A